7096 · StemCell Institute Inc. · Financials
Market Cap
6.56B JPY
Shares
10.07M
Volume · Nov 13
41.7K
Avg daily vol (3M)
5185
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
2.81B
+4.9%
FY2026
Net Income
155.92M
-59.6%
FY2026
Gross Margin
60.9%
-2.3pp
FY2026
Operating Margin
7.21%
-8.4pp
FY2026
Operating Cash Flow
73.51M
-84.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 2.81B | 2.68B | 2.48B | 2.09B | 1.78B |
| JPY | 1.1B | 987.09M | 905.31M | 755.45M | 670.69M |
| JPY | 1.71B | 1.69B | 1.58B | 1.34B | 1.11B |
| JPY | 202.66M | 418.51M | 413.76M | 297.56M | 226.95M |
| JPY | 217.79M | 565.71M | 441.33M | 278.96M | 212.55M |
| JPY | 86.78M | 179.92M | 130.35M | 80.92M | 78.83M |
| JPY | 155.92M | 385.8M | 310.98M | 198.03M | 133.73M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 256.05M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.